Glucocorticoid-induced osteoporosis: prevention and treatment.
Werth
V P
VP
Department of Dermatology, University of Pensylvania, Philadelphia 19104-4283, USA.
D000280:Administration, Inhalation; D001862:Bone Resorption / Q000139:chemically induced* / Q000503:physiopathology; D002116:Calcitonin / Q000008:administration & dosage / Q000627:therapeutic use; D004164:Diphosphonates / Q000008:administration & dosage / Q000627:therapeutic use; D005260:Female; D005938:Glucocorticoids / Q000009:adverse effects* / Q000627:therapeutic use; D006801:Humans; D008297:Male; D010024:Osteoporosis / Q000139:chemically induced* / Q000188:drug therapy* / Q000517:prevention & control; D015663:Osteoporosis, Postmenopausal / Q000139:chemically induced / Q000188:drug therapy / Q000517:prevention & control; D011379:Prognosis; D012216:Rheumatic Diseases / Q000188:drug therapy
D004164:Diphosphonates; D005938:Glucocorticoids; D002116:Calcitonin